BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 26662664)

  • 1. Treatment with Anti-FcεRIα (MAR-1) Antibody Prevents Acute Islet Allograft Rejection in a Murine Model.
    Yazawa N; Imaizumi T; Makuuchi H; Tsuchiya I; Tanaka M; Inokuchi S; Habu S; Nakagohri T
    Tokai J Exp Clin Med; 2015 Dec; 40(4):141-8. PubMed ID: 26662664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of islet engraftment and achievement of long-term islet allograft survival by Toll-like receptor 4 blockade.
    Giovannoni L; Muller YD; Lacotte S; Parnaud G; Borot S; Meier RP; Lavallard V; Bédat B; Toso C; Daubeuf B; Elson G; Shang L; Morel P; Kosco-Vilbois M; Bosco D; Berney T
    Transplantation; 2015 Jan; 99(1):29-35. PubMed ID: 25340601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operational immune tolerance towards transplanted allogeneic pancreatic islets in mice and a non-human primate.
    Abdulreda MH; Berman DM; Shishido A; Martin C; Hossameldin M; Tschiggfrie A; Hernandez LF; Hernandez A; Ricordi C; Parel JM; Jankowska-Gan E; Burlingham WJ; Arrieta-Quintero EA; Perez VL; Kenyon NS; Berggren PO
    Diabetologia; 2019 May; 62(5):811-821. PubMed ID: 30701283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
    Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
    Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
    Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
    Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts.
    Takeda Y; Gotoh M; Dono K; Nishihara M; Grochowiecki T; Kimura F; Yoshida T; Ohta Y; Ota H; Ohzato H; Umeshita K; Takeda T; Matsuura N; Sakon M; Kayagaki N; Yagita H; Okumura K; Miyasaka M; Monden M
    Diabetologia; 1998 Mar; 41(3):315-21. PubMed ID: 9541172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
    Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ingested interferon-alpha prevents allograft islet transplant rejection.
    Brod SA; Katz S; Phan T; Stepkowski S
    Transplantation; 2000 May; 69(10):2162-6. PubMed ID: 10852617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of the OX40/OX40L pathway and induction of PD-L1 synergistically protects mouse islet allografts from rejection.
    Li T; Ma R; Zhu J; Wang F; Huang L; Leng X
    Chin Med J (Engl); 2014; 127(14):2686-92. PubMed ID: 25043090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential immunosuppressive effect of anti-lymphocyte function-associated antigen-1 monoclonal antibody on islet transplantation.
    Gotoh M; Fukuzaki T; Monden M; Dono K; Kanai T; Yagita H; Okumura K; Mori T
    Transplantation; 1994 Jan; 57(1):123-6. PubMed ID: 7904780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic Trioxide Induces T Cell Apoptosis and Prolongs Islet Allograft Survival in Mice.
    Gao C; Jiang J; Ma P; Cheng P; Lian Y; Zhao B; Li C; Peng Y; Wang F; Lin Y; Jin N; Li J; Wang L; Li Q; Leng Y; Xia J; Qi Z
    Transplantation; 2015 Sep; 99(9):1796-806. PubMed ID: 25919768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of Toll-like receptors in allogeneic islet transplantation.
    Ro H; Hong J; Kim BS; Lee EW; Kim MG; Han KH; Yeom HJ; Lee EM; Jeong JC; Oh KH; Ahn C; Yang J
    Transplantation; 2012 Nov; 94(10):1005-12. PubMed ID: 23169223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 4 suppression leads to islet allograft survival.
    Goldberg A; Parolini M; Chin BY; Czismadia E; Otterbein LE; Bach FH; Wang H
    FASEB J; 2007 Sep; 21(11):2840-8. PubMed ID: 17475921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low energy X-ray (grenz ray) treatment of purified islets prior to allotransplant markedly decreases passenger leukocyte populations.
    Pawlick R; Gala-Lopez B; Pepper AR; Abualhassan N; Bruni A; Suzuki K; Rayat G; Elliott JF; Shapiro AMJ
    Islets; 2017 Jul; 9(4):e1330742. PubMed ID: 28692319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of LIGHT/HVEM and B7/CD28 signaling facilitates long-term islet graft survival with development of allospecific tolerance.
    Fan K; Wang H; Wei H; Zhou Q; Kou G; Hou S; Qian W; Dai J; Li B; Zhang Y; Zhu T; Guo Y
    Transplantation; 2007 Sep; 84(6):746-54. PubMed ID: 17893608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
    Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
    J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance.
    Montane J; Obach M; Alvarez S; Bischoff L; Dai DL; Soukhatcheva G; Priatel JJ; Hardenberg G; Levings MK; Tan R; Orban PC; Verchere CB
    Cell Transplant; 2015; 24(10):2143-54. PubMed ID: 26423995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.